For lung cancer, major pathways included mitotic regulation, metabolic reprogramming, and tight junction integrity, having highly enriched genes such as MYBL2 (driving cell cycle) and FOLR1 (facilitating tumor growth through folate metabolism). Here, FOLR1 is linked to lung carcinoma.